Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

The document concludes that successful treatment of upper and midface trauma should focus on restoring both appearance and function, with attention to facial structure, skin, and hair repair.

Latisse (bimatoprost 0.03%) is widely used in dermatology but the document doesn't give detailed evidence or numbers.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Using travoprost for glaucoma may cause extra hair growth and darker skin around the eyes, but these effects can reverse after stopping the drug.

Hand-foot-mouth disease may cause nail loss in children.

Hair casts are often mistaken for head lice, scalp pain in hair loss is linked to certain nerve factors, eyelash growth treatment is safe and effective, and nail shedding in children may follow hand-foot-mouth disease.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

The book is a detailed and useful guide for doctors learning about hair transplantation.

The document concludes that using small hair grafts has improved facial and scalp hair restoration.

Eye drops with β-blockers may cause hair loss.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

A new classification and scoring system is needed for alopecia areata to better assess severity.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Stopping heptaminol medication reversed hair color loss in a patient on dialysis.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

Hair loss significantly lowers quality of life for cancer patients.

A 5-year-old boy with alopecia totalis had temporary hair regrowth with treatment but relapsed, highlighting the need for thorough investigation and holistic care.

Oral tofacitinib successfully treated total body hair loss in one patient.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

An 8-year-old girl has a rare, irreversible hair loss condition caused by a genetic mutation.

Latanoprost's effectiveness for hair growth is not confirmed but shows promise, needing more research.

A man with severe leprosy developed painless ulcers and numbness, treated successfully with multiple drugs and vitamins.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Hair loss may be linked to imbalances in trace elements.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

The pigment in black eyeliner can spread in the skin and may cause permanent eyelash loss.

The document suggests using hairpieces, wigs, and safe cosmetic techniques to hide hair loss from alopecia areata.

Alopecia areata negatively impacts quality of life and work, even with moderate hair loss.